Back to search
A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results
Data up to Jan 2025
Published2004
Citations3
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...